Sutimlimab
Sutimlimab is a novel monoclonal antibody targeting complement protein C1. Sutimlimab is commonly used as a C1 inhibitor to treat cold agglutina-associated hemolysis.
Product Specifications
CAS Number
2049079-64-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Complement System
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS075301 Inquire
Chicken Immune Receptor Expressed On Myeloid Cells 1 ELISA Kit
Sign In for Pricing
View Details 
MBS7055916 Inquire
Recombinant Nothoprocta perdicaria Cytochrome c oxidase subunit 2 (MT-CO2), partial
Sign In for Pricing
View Details 
K4420307 1.0 µg DNA
Cd69 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details